Cambridge biotech Sage to open postpartum depression support center in North Carolina

Sage is awaiting possible FDA approval of a drug for PPD, which affects an estimated 10 to 20 percent of new mothers in the U.S.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.